Prozac (fluoxetine) lingers in your body far longer than most antidepressants. After you take your last dose, the drug itself has a half-life of one to four days, but its active breakdown product, norfluoxetine, sticks around with a half-life of seven to fifteen days. That means traces of the drug’s active effects can persist for weeks, and its influence on your liver enzymes can last even longer. The full timeline depends on your age, genetics, liver health, and how long you were taking the medication.
Two Half-Lives, Not One
Most people think of a drug’s half-life as a single number, but Prozac complicates that picture. Your liver converts fluoxetine into a metabolite called norfluoxetine, which is pharmacologically active, meaning it keeps doing roughly the same job as the parent drug. Fluoxetine itself has a half-life of about one to four days after a single dose, but norfluoxetine’s half-life ranges from seven to fifteen days.1PubMed. Clinical pharmacokinetics of fluoxetine When pharmacologists talk about how long Prozac stays in your system, they have to account for both substances, because norfluoxetine is the one that hangs on.
After repeated daily dosing, the picture changes further. With chronic use, fluoxetine’s effective half-life stretches to roughly six days because the drug inhibits the very liver enzyme responsible for breaking it down.2PubMed. Clinical pharmacokinetics of selective serotonin reuptake inhibitors This self-slowing effect is part of why Prozac behaves differently from other SSRIs and why the timeline for clearing it is unusually long.
How Long Until It Is Fully Gone
A rough rule of thumb is that it takes about five half-lives for a drug to drop below clinically meaningful levels. For fluoxetine itself after chronic dosing, five half-lives of roughly six days each puts you at around 30 days. But norfluoxetine, with its own half-life of up to 15 days, needs five half-lives of its own, which stretches to roughly 75 days, or about two and a half months. In practice, most healthy adults who stop Prozac will still have detectable active metabolite levels circulating for well over a month. For people on higher doses or longer treatment courses, the tail end of elimination can reach two to three months.
This long tail is unusual among antidepressants. Drugs like paroxetine or sertraline have much shorter half-lives and clear the body in days to a couple of weeks. Prozac’s extended presence is both a benefit and a complication, depending on the situation.
Reaching Steady State Takes Weeks
Just as Prozac takes a long time to leave, it also takes a long time to build up to stable levels when you start. Unlike some other SSRIs that reach steady state within about one to two weeks, fluoxetine and especially norfluoxetine take weeks to plateau.3PubMed. Pharmacokinetics of the selective serotonin reuptake inhibitors This slow buildup is why your prescriber may tell you to give Prozac a month or more before judging whether it is working. The flip side is equally important: dose changes also take weeks to fully register in your blood levels, so adjustments require patience.
Your Genetics Can Double or Triple the Timeline
Fluoxetine is primarily broken down in the liver by an enzyme called CYP2D6. The gene coding for this enzyme is one of the most variable in the human genome, and your particular version dramatically affects how fast you process the drug. People are generally categorized as normal metabolizers, intermediate metabolizers, poor metabolizers, or ultra-rapid metabolizers.
In one study, people classified as poor metabolizers of CYP2D6 had fluoxetine peak levels about 57% higher than normal metabolizers, and the drug’s elimination half-life was about three times longer.4PubMed. The disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquin They also converted much less fluoxetine into norfluoxetine, meaning the parent drug itself lingered at higher concentrations for longer. For a poor metabolizer, the “five half-lives to clear” calculation could put total clearance well beyond four months after the last dose.
Research on dose-adjusted blood concentrations confirms the pattern: poor metabolizers had roughly 70% higher fluoxetine levels per milligram of dose, while their norfluoxetine levels were about half those of normal metabolizers.5PubMed Central. Impact of CYP2D6 genotype on fluoxetine exposure and treatment switch in adults and children/adolescents Interestingly, when researchers looked at the total active substance (fluoxetine plus norfluoxetine combined), the differences between genetic groups were smaller, because what poor metabolizers lose in norfluoxetine they partly make up for by retaining more of the parent drug. Still, the overall timeline for elimination is extended in poor metabolizers, and side effects at standard doses tend to be more pronounced.
About 5 to 10 percent of people of European descent are CYP2D6 poor metabolizers, and the frequency varies across populations. Most people have no idea what their status is unless they have had pharmacogenomic testing. If you have found that Prozac’s side effects are unusually intense or long-lasting, this genetic variation could be part of the explanation.
Prozac Slows Down Its Own Metabolism
Adding another layer to the timeline, fluoxetine and norfluoxetine both bind tightly to CYP2D6 and inhibit it. This means the drug actively slows down the enzyme responsible for clearing it. Research suggests this is primarily competitive inhibition: because fluoxetine and norfluoxetine have strong affinity for CYP2D6 and circulate at significant levels for a long time, they effectively block the enzyme from processing other drugs as well.6PubMed Central. Assessing the Mechanism of Fluoxetine-Mediated CYP2D6 Inhibition
This autoinhibition is one reason the half-life stretches after weeks of dosing compared to a single dose. It also means that even after you stop taking Prozac, the enzyme does not bounce back immediately. We will return to that point shortly, because the enzyme recovery timeline is one of the most practically important and least discussed aspects of stopping Prozac.
Age Changes the Math Substantially
Elderly individuals clear fluoxetine more slowly. Modeling studies suggest that older adults reach roughly twice the fluoxetine exposure of younger adults during chronic dosing, and about one and a half times the total active substance levels.7PubMed Central. Application of Physiologically Based Pharmacokinetic Modeling to Optimize Assessment of Age-Related Fluoxetine Accumulation in the Elderly Steady state also takes longer to reach, meaning the drug accumulates more before leveling off.
Within the elderly population, sex matters too. Older women have been found to have higher norfluoxetine levels than men of the same age, and the norfluoxetine half-life is longer in patients over 75.8Gerontology. Pharmacokinetics of Fluoxetine in Elderly Men and Women For an older woman on Prozac, the washout period after discontinuation could be considerably longer than the standard estimates, which are mostly derived from studies in younger adults.
On the other end of the age spectrum, children tend to have higher fluoxetine and norfluoxetine concentrations than adolescents at the same dose. Once researchers accounted for body weight, however, the levels were similar between the two groups, indicating that the difference is mostly about body size rather than some unique pediatric metabolic pathway.9PubMed. Fluoxetine pharmacokinetics in pediatric patients
Liver Disease Extends Elimination Dramatically
Because fluoxetine depends almost entirely on the liver for breakdown, liver disease can slow its clearance to a crawl. In patients with stable alcoholic cirrhosis, the half-life of fluoxetine roughly tripled compared to people with healthy livers, going from about 2.2 days to 6.6 days. Plasma clearance dropped by more than half. The formation of norfluoxetine was also reduced, and norfluoxetine clearance was slower as well.10PubMed. Fluoxetine disposition and elimination in cirrhosis The practical consequence is that both the parent drug and its metabolite accumulate to higher levels during treatment and take much longer to wash out after stopping. Prescribers typically use lower doses in patients with liver disease for this reason.
Kidney Disease Has Surprisingly Little Effect
You might assume that impaired kidneys would slow the elimination of any drug, but fluoxetine is an exception. Research comparing depressed patients with kidney failure, including those on dialysis, to patients with normal kidney function found that renal impairment and the hemodialysis process did not meaningfully alter the levels of either fluoxetine or norfluoxetine.11PubMed. Fluoxetine in depressed patients with renal failure and in depressed patients with normal kidney function This makes sense because fluoxetine is metabolized almost entirely by the liver, not filtered by the kidneys. Dialysis also fails to remove it because the drug binds tightly to proteins in the blood. For people with kidney problems, Prozac’s timeline is essentially the same as for anyone else with normal liver function.
The Enzyme Recovery Timeline After Stopping
Here is where things get clinically interesting and where many patients and even some clinicians underestimate Prozac’s reach. After you stop taking fluoxetine, the drug’s inhibition of CYP2D6 does not vanish when the last pill clears your blood. In a study comparing the enzyme recovery timelines of three SSRIs, fluoxetine’s inhibition of CYP2D6 had a half-life of about seven days, compared to roughly three days for both paroxetine and sertraline.12Journal of Clinical Psychopharmacology. Differential Time Course of Cytochrome P450 2D6 Enzyme Inhibition by Fluoxetine, Sertraline, and Paroxetine in Healthy Volunteers
More striking was the time for enzyme activity to fully return to baseline. For fluoxetine, that took an average of about 63 days. By comparison, paroxetine’s enzyme inhibition resolved in about 20 days and sertraline’s in about 25 days. Even at 42 days after the last fluoxetine dose, CYP2D6 activity was still measurably suppressed. This has real consequences: if you start a new medication that depends on CYP2D6 for processing shortly after stopping Prozac, that medication may behave as if you were taking a higher dose than prescribed because the enzyme is not yet fully recovered.
This extended enzyme suppression is something to discuss with your prescriber when switching medications. It is not just about waiting for fluoxetine to clear your bloodstream. You also need to wait for the downstream metabolic effects to resolve.
Why Withdrawal Symptoms Are Delayed
One practical benefit of Prozac’s slow exit is that discontinuation symptoms tend to appear later and often less severely than with shorter-acting SSRIs. While paroxetine withdrawal can begin within two days of stopping, fluoxetine withdrawal symptoms, when they occur, typically do not appear until two to six weeks later.13The Lancet Psychiatry. Why Antidepressant Withdrawal Is so Difficult and What Can Be Done About It The drug essentially tapers itself because it leaves so slowly.
This built-in taper is actually one reason prescribers sometimes switch patients to fluoxetine before discontinuing antidepressants altogether. If someone is struggling with withdrawal from a shorter-acting SSRI, a temporary switch to fluoxetine can smooth the process. That said, “delayed” does not mean “absent.” Some people do experience withdrawal symptoms from Prozac, and because the delay is so long, they sometimes fail to connect symptoms appearing a month later to the medication they stopped.
Switching to Another Antidepressant
The long washout period after stopping Prozac creates a specific challenge when transitioning to a new medication. Conservative switching strategies involve gradually tapering the first drug, waiting through an adequate washout period, and then starting the new one.14PubMed Central. Switching and stopping antidepressants With Prozac, that washout is substantially longer than with other SSRIs.
The particular concern when switching from fluoxetine to a monoamine oxidase inhibitor is the risk of serotonin syndrome, a potentially dangerous condition caused by excessive serotonin activity. Most guidelines recommend waiting at least five weeks after stopping Prozac before starting an MAOI, specifically because of norfluoxetine’s extended half-life. For switches to other SSRIs or serotonin-norepinephrine reuptake inhibitors, shorter waiting periods may be acceptable, but the lingering CYP2D6 inhibition described earlier still needs to be factored in. If the new drug is processed by CYP2D6, its blood levels could be higher than expected for the first month or two.
Prozac, Breastfeeding, and Infant Exposure
The same pharmacokinetic properties that make Prozac slow to leave an adult’s body also affect breastfeeding considerations. Fluoxetine is more likely than other SSRIs to show up at measurable levels in breast milk and in the infant’s blood. This is a direct consequence of its long half-life and the persistence of norfluoxetine.15PubMed Central. Antidepressant Medication Use during Breastfeeding Additionally, babies exposed in utero may have residual levels at birth from prenatal loading, on top of what they receive through breast milk. For this reason, some prescribers prefer shorter-acting SSRIs like sertraline for nursing mothers, though the decision always depends on the individual clinical picture.
Will Prozac Show Up on a Drug Test
Standard workplace drug panels test for substances like amphetamines, opioids, and THC. They do not test for fluoxetine, and Prozac is not a controlled substance. However, there have been occasional reports of fluoxetine causing false positives on immunoassay-based urine screens, particularly for amphetamines or benzodiazepines. These are false positives that would not be confirmed on a follow-up test using more specific methods.
If you are being tested specifically for fluoxetine, say in a clinical monitoring context, laboratory methods can detect fluoxetine and norfluoxetine in urine at concentrations as low as 10 micrograms per liter.16Talanta. Development and validation method for determination of fluoxetine and its main metabolite norfluoxetine by nonaqueous capillary electrophoresis in human urine Given norfluoxetine’s long half-life, such tests could detect prior Prozac use for two months or more after the last dose, depending on how long you were taking it and the sensitivity of the assay.
Receptor Effects May Outlast Blood Levels
There is an additional nuance that rarely comes up in standard pharmacokinetic discussions. Even after a drug’s blood concentration drops, its effects at the cellular level can persist. Research into serotonin transporter occupancy has found that for some antidepressants, the degree of transporter blockade decreases more slowly than the plasma concentration.17Molecular Psychiatry. The relationship between dose and serotonin transporter occupancy of antidepressants—a systematic review In other words, the brain effects of the drug may linger slightly beyond what blood levels alone would predict. This has not been studied extensively for fluoxetine specifically, but it is consistent with clinical experience: patients sometimes describe feeling the effects of Prozac for longer than pharmacokinetic models would suggest.
Combined with the enzyme inhibition timeline, receptor-level persistence means that the functional footprint of Prozac in your body extends beyond what a simple blood test for the drug would capture. The drug may be gone from your plasma, but its downstream effects on brain chemistry and liver enzyme function can persist for weeks afterward.
Obesity and Body Size
Given that fluoxetine is highly fat-soluble, you might expect obesity to significantly change how long the drug stays in your system. Lipophilic drugs tend to distribute into fatty tissue and release slowly, potentially extending elimination. However, the available pharmacokinetic data suggests that obesity does not meaningfully alter fluoxetine’s overall elimination profile.1PubMed. Clinical pharmacokinetics of fluoxetine The reasons for this are not entirely clear, but it may reflect the fact that the liver’s metabolic capacity, not tissue storage, is the primary bottleneck in fluoxetine clearance. So while body weight influences dosing in children, weight alone does not appear to extend the washout period in adults to a clinically significant degree.